Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with...
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis
About this item
Full title
Author / Creator
Ye, Ruiting , Zeng, Han , Liu, Zhaopei , Jin, Kaifeng , Liu, Chunnan , Yan, Sen , Yu, Yanze , You, Runze , Zhang, Hongyi , Chang, Yuan , Wang, Yiwei , Liu, Li , Zhu, Yu , Xu, Jiejie , Xu, Le and Wang, Zewei
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
Latency-associated peptide (LAP) was identified as crucial immune regulator in tumor microenvironment (TME) in recent researches. In this study, we aimed to estimate the predictive value of LAP expression for clinical survival and therapeutic response in muscle-invasive bladder cancer (MIBC).
Methods
Our study encompassed 140 MI...
Alternative Titles
Full title
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10992091
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10992091
Other Identifiers
ISSN
0340-7004
E-ISSN
1432-0851
DOI
10.1007/s00262-021-02987-4
